Prevent cuts to NIH biomedical research that would raise health care costs, delay treatment breakthroughs, and undermine chronic disease cures.

An amendment that would direct the Senate to prevent cuts to the National Institutes of Health’s biomedical research that would raise health care costs, delay treatment breakthroughs, and undermine efforts to cure chronic disease.

Alsobrooks filed an amendment to prevent cuts to NIH biomedical research.

Senator Alsobrooks Forces Vote Capping Child Care Costs at 7% of Income
primary · speech · model gpt-5.5

unverified · Source version 25571 · locator unknown

Alsobrooks urged HHS to restore NIH operations to prevent further research disruptions.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Early in her Senate term, Alsobrooks joined an official letter demanding restoration of NIH study sections, advisory committees, communications, travel, and staffing functions after Trump administration restrictions disrupted the grant process.

partial same_term A for effort

Van Hollen, Alsobrooks, Raskin Sound Alarm on NIH Disruptions, Urge Immediate Restoration of Operations
secondary · model gpt-5.5 · confidence 90%

unverified · Source version 25572 · locator unknown

The letter asked NIH to rescind guidance causing abrupt and deeply damaging research cuts.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Alsobrooks and Maryland colleagues directly opposed NIH indirect-cost guidance that would cut reimbursements for Maryland research institutions and clinical trials, citing risks to cures, patients, jobs, and biomedical research capacity.

partial same_term A for effort

February 20, 2025 NIH Letter to HHS and NIH
secondary · model gpt-5.5 · confidence 93%

unverified · Source version 25573 · locator unknown

The resolution opposed NIH interruption, delay, or funding disruption and defended NIH workforce capacity.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Congress.gov records S.Res.93 as an official Senate resolution cosponsored by Alsobrooks supporting uninterrupted NIH operations and funding. It is concrete legislative action, but a resolution alone did not enact funding protection.

partial same_term A for effort

S.Res.93 - NIH Operations and Workforce Resolution
secondary · model gpt-5.5 · confidence 88%

unverified · Source version 25574 · locator unknown

NIH reported FY2025 biomedical research investment grew and its total FY2025 appropriation was $48.5 billion.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Official NIH data show that, despite attempted administrative disruptions, overall NIH FY2025 biomedical research grant investment and research project grant funding increased rather than being cut.

delivered same_term

Fiscal Year 2025 By the Numbers: Extramural Grant Investments in Research
secondary · model gpt-5.5 · confidence 90%

unverified · Source version 25575 · locator unknown

The bill provided $48.7 billion for NIH biomedical investments in research.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The FY2026 Labor-HHS appropriations package approved by Congress funded NIH biomedical research at $48.7 billion, including targeted funding for cancer, Alzheimer’s, diabetes, ALS, rare disease, and related research, preventing a broad NIH cut in enacted appropriations.

delivered same_term

Congress Approves FY 2026 Labor, HHS, Education Appropriations Bill
secondary · model gpt-5.5 · confidence 91%

unverified · Source version 25576 · locator unknown

On H.R.7148 passage, the bill passed 71-29; Alsobrooks voted Nay.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Although the final FY2026 appropriations bill preserved NIH funding, Alsobrooks voted against final Senate passage. This limits personal fulfillment credit to partial, even though she took other concrete actions opposing NIH cuts.

partial same_term

U.S. Senate Roll Call Vote 20, 119th Congress, 2nd Session
secondary · model gpt-5.5 · confidence 94%

verified · Source version 86708 · locator 942

This Act (CR) continues government operations through December 11, 2026 at the Fiscal Year (FY) 2026 enacted level. The CR also prohibits NIH from implementing the revisions to the Uniform Administrative Requirements for Federal Awards

Fetched verbatim passage. AI summary (separate from source): NIH officially stated during the lookback window that HHS/NIH is operating under Public Law 119-103 at FY2026 enacted levels through December 11, 2026, and that NIH is barred from implementing the Uniform Guidance revisions during that period. This is a temporary prevention of NIH-related funding/grantmaking disruption, not a full-year FY2027 resolution.

partial same_term

NOT-OD-26-131: NIH Operates Under a Continuing Resolution
secondary · model gpt-5.5 · confidence 94%

unverified · Source version 86710 · locator unknown

through December 11, 2026, a rule to revise the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (commonly known as the ‘‘Uniform Guidance’’), arising out of the notice of proposed rulemaking titled ‘‘Regulation for Federal Financial Assistance’’, which was published in the Federal Register on May 29, 2026, or a substantially similar rule, shall not be issued or finalized.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The enacted stopgap law temporarily blocked the administration’s proposed grant-rule overhaul, which NIH later identified as applying to NIH. This supports partial fulfillment because it prevented a concrete threat to biomedical grantmaking only through December 11, 2026.

partial same_term

PLAW-119publ103.pdf
secondary · model gpt-5.5 · confidence 93%

unverified · Source version 86712 · locator unknown

Question: On Passage of the Bill (H.R. 6500, as amended ) Vote Result: Bill Passed Alsobrooks (D-MD), Yea

Unverified model/legacy excerpt; not proof. AI summary (separate from source): Alsobrooks voted for H.R. 6500, the continuing appropriations bill that became Public Law 119-103 and temporarily maintained FY2026 operations while blocking the Uniform Guidance rule. This is concrete same-term effort toward preventing NIH cuts/disruption.

partial same_term A for effort

U.S. Senate Roll Call Vote 228, 119th Congress, 2nd Session
secondary · model gpt-5.5 · confidence 91%

verified · Source version 86714 · locator 8010

We write to call on you to abandon any plan to exert political control over NIH’s grant-making decisions — whether that’s through your proposed rule, a new Executive Order, or any other means

Fetched verbatim passage. AI summary (separate from source): Within the lookback window, Alsobrooks signed an official Senate letter opposing renewed executive efforts to politicize NIH grantmaking. The letter documents ongoing threat and continued effort, but it is a demand rather than final enactment.

partial same_term A for effort

letter_to_vought_nih_eo.pdf
secondary · model gpt-5.5 · confidence 90%

unverified · Source version 86714 · locator unknown

To date, the Trump administration has terminated or disrupted 5,780 NIH grants worth an estimated $15 billion. Today, 1,231 of those grants still have not been restored.

Unverified model/legacy excerpt; not proof. AI summary (separate from source): The same September 25 Senate letter states that many NIH grant disruptions remained unresolved as of the lookback window, which limits the promise outcome to partial despite appropriations and temporary protections.

partial same_term

letter_to_vought_nih_eo.pdf
secondary · model gpt-5.5 · confidence 87%